← Browse by Condition
Medical Condition

refractory solid tumor

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06375564 Phase 1
Recruiting

Clinical Evaluation of 177Lu-AB-3PRGD2 in Various Solid Tumors With Integrin αvβ3 Positive Expression

Enrollment
20 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →